SCHEMBL19911501

SCHEMBL19911501

C=CCn1nnc2cc(OC)ccc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.44
HCAR3 P49019 2/20 0.44
MGAM O43451 2/20 0.42
AMY1A P0DUB6 2/20 0.42
GAA P10253 2/20 0.42
SI P14410 2/20 0.42
MGAM2 Q2M2H8 2/20 0.42
PDE4B Q07343 2/20 0.42
PDE4D Q08499 1/20 0.42
TDP1 Q9NUW8 1/20 0.41
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
TP53 P04637 1/20 0.41
HPGD P15428 1/20 0.41
TSHR P16473 1/20 0.41
HTT P42858 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HSD17B10 Q99714 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
NPC1 O15118 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19848717 0.88 HDAC3 (0.44) MAPTMGAMAMY1AGAASI
SCHEMBL29411837 0.85 HCAR3 (0.47) MAPTHCAR3MGAMAMY1AGAA
SCHEMBL19848202 0.81 MAPT (0.61) MAPTHCAR3MGAMAMY1AGAA
SCHEMBL19911508 0.80 HCAR3 (0.47) MAPTHCAR3MGAMAMY1AGAA
SCHEMBL19911513 0.80 HCAR3 (0.47) MAPTHCAR3MGAMAMY1AGAA
SCHEMBL19848519 0.80 NAMPT (0.43) MAPTHCAR3MGAMAMY1AGAA
SCHEMBL19911504 0.79 HCAR3 (0.57) MAPTHCAR3MGAMAMY1AGAA
SCHEMBL19848208 0.77 KDM4E (0.46) MAPTHCAR3KDM4EALDH1A1HPGD
SCHEMBL203857 0.77 SLC9A1 (0.44) HCAR3MGAMAMY1AGAASI
SCHEMBL19848744 0.77 GRM2 (0.42) HCAR3ALDH1A1HTTSMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10756394-B2 Nonaqueous electrolyte and nonaqueous secondary battery ASAHI KASEI KABUSHIKI KAISHA (JP) 2020-08-25 US disclosed
EP-3467930-A1 NONAQUEOUS ELECTROLYTE AND NONAQUEOUS SECONDARY BATTERY ASAHI KASEI KABUSHIKI KAISHA (JP) 2019-04-10 EP disclosed
US-20180062213-A1 Nonaqueous Electrolyte and Nonaqueous Secondary Battery ASAHI KASEI KABUSHIKI KAISHA (JP) 2018-03-01 US disclosed
US-20180062213-A1 Nonaqueous Electrolyte and Nonaqueous Secondary Battery ASAHI KASEI KABUSHIKI KAISHA (JP) 2018-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10756394-B2 Nonaqueous electrolyte and nonaqueous secondary battery BPTF, BRD4, KCNN2 MAPT 1283/4885HCAR3 4636/4885MGAM 3479/4885
US-20180062213-A1 Nonaqueous Electrolyte and Nonaqueous Secondary Battery BPTF, BRD4, KCNN2 MAPT 1283/4885HCAR3 4636/4885MGAM 3479/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.